TELESTA THERAPEUTICS INC T.TST

be careful

[buisnessguy]

This stock has been undervalued for so long for a good reason maybe. betting on fda may still be too far away. a second phase 3 trail might be in the works imo. Just because its the only bladder drug to be developed in a while doesnt make it a winner. traded for months well below fair value and seems like traders are in to make a quick buck. back to .37. hope im wrong

[bailmeout]

Welcome to the tst bullboard..We are so glad you could join..just to help us out here I'm sure. Thanks for the heads up..lol buisnessguy Member Since: November 3, 2015

[greenbacks]

Hey Bus... You are not telling us anything that we don't already know about a possible second phase 3. But based on the article: Use of Multiple Endpoints and Approval Paths Depicts a Decade of FDA Oncology Drug Approvals, we look to be in good shape.  Not to mention, most of us don't likely have a lot of downside on this trade at .37  On the flipside, this could become a first

[Frogger2]

You should put some effort into thorough research before you comment on past valuation history; providing your future stock price estimates. Where's your information? Although there are a few posters here with questionable agendas or are just plain nuts, most here are well informed, have completed their DD and fully aware of any risk which is a personal choice. You have been here for four